IDEC Pharmaceuticals' IPO

IDEC Pharmaceuticals raised a round of funding on September 01, 1991. Investors include Public.

Producer of antibody-based treatment for lymphoma. The company completed an IPO and later merged with Biogen (Nasdaq: BIIB).…

Articles about IDEC Pharmaceuticals' IPO: